| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1196/ANNALS.1313.014 |
| P698 | PubMed publication ID | 16014527 |
| P50 | author | Andreas Radbruch | Q18410254 |
| Falk Hiepe | Q47265876 | ||
| P2093 | author name string | Falk Hiepe | |
| Rudolf A Manz | |||
| Bimba F Hoyer | |||
| P2860 | cites work | Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice | Q47991495 |
| Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. | Q52950179 | ||
| Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response. | Q52956500 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 124-133 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Long-lived plasma cells and their contribution to autoimmunity | |
| P478 | volume | 1050 |
| Q79761733 | Allogeneic haematopoietic stem cell transplantation for severe autoimmune diseases: great expectations but controversial evidence |
| Q48519153 | Anti-CD20 Cell Therapies in Multiple Sclerosis-A Fixed Dosing Schedule for Ocrelizumab is Overkill |
| Q45212505 | Are autoantibodies the targets of B-cell-directed therapy? |
| Q36749750 | B cells establish, but do not maintain, long-lived murine anti-peanut IgE(a). |
| Q34544062 | B cells move to centre stage: novel opportunities for autoimmune disease treatment |
| Q36764935 | Biological therapies: new treatment options for ANCA-associated vasculitis? |
| Q24657562 | CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche |
| Q33373065 | Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome. |
| Q36585041 | Does our current understanding of the molecular basis of immune tolerance predict new therapies for autoimmune disease? |
| Q37512037 | Follicular B cells in thyroids of mice with spontaneous autoimmune thyroiditis contribute to disease pathogenesis and are targets of anti-CD20 antibody therapy |
| Q38570322 | Functional autoantibodies in systemic sclerosis |
| Q33518486 | Functional memory B cells and long-lived plasma cells are generated after a single Plasmodium chabaudi infection in mice |
| Q28081911 | Gene therapy for hemophilia |
| Q35839239 | Germinal center architecture disturbance during Plasmodium berghei ANKA infection in CBA mice |
| Q58908910 | Hematopoietic stem cell transplantation for systemic lupus erythematosus |
| Q37311073 | Hematopoietic stem cell transplantation for systemic lupus erythematosus, the antiphospholipid syndrome and bullous skin diseases |
| Q96109996 | Immunoglobulin M bullous pemphigoid: An enigma |
| Q50158318 | Impact and Modulations of Peripheral and Edaphic B Cell Subpopulations in Chronic Rhinosinusitis With Nasal Polyposis |
| Q51023029 | Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation. |
| Q36707550 | Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors |
| Q38818380 | Obinutuzumab for the treatment of indolent lymphoma |
| Q34707354 | Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease |
| Q33971785 | Relevance of rituximab therapy in pemphigus vulgaris: analysis of current data and the immunologic basis for its observed responses |
| Q36138154 | Resetting the adaptive immune system after autologous stem cell transplantation: lessons from responses to vaccines |
| Q33740847 | Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritis |
| Q33798060 | Robust memory responses against influenza vaccination in pemphigus patients previously treated with rituximab |
| Q43775404 | Sample stability and variability of B-cell subsets in blood from healthy subjects and patients with systemic lupus erythematosus |
| Q33421964 | Severe and fatal adverse events risk associated with rituximab addition to B-cell non-Hodgkin's lymphoma (B-NHL) chemotherapy: a meta-analysis |
| Q86413750 | Sjögren's syndrome associated chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) treated with autologous and subsequently allogeneic haematopoietic SCT (HSCT) |
| Q89777486 | Successful desensitization with proteasome inhibition and costimulation blockade in sensitized nonhuman primates |
| Q35828841 | T cell-dependent survival of CD20+ and CD20- plasma cells in human secondary lymphoid tissue. |
| Q53443452 | The origin of increasing utilization of hematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (SAD). Introduction. |
| Q43697917 | The tyrosine kinase Lyn limits the cytokine responsiveness of plasma cells to restrict their accumulation in mice |
| Q49891919 | Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter study. |
| Q51988521 | [Autoantibodies and antibody-secreting cells]. |
| Q52850241 | [Therapy-resistant cells of the B cell line]. |
| Q81477489 | [[Treatment of therapy resistant pemphigus vulgaris with rituximab and immunoglobulins] |
Search more.